Inspur Software (600756.SH) issues a profit warning, expecting a net profit of around 12 million yuan for the fiscal year 2024, a significant decrease compared to the previous year.
Wave Software (600756.SH) announced that the company is expected to achieve net profit attributable to the parent company in the 2024 fiscal year...
Inspur Software (600756.SH) announced that the company expects to achieve a net profit attributable to the owners of the parent company of approximately 12 million yuan in the fiscal year 2024. In the same period last year, the net profit attributable to the owners of the parent company was 90.9887 million yuan.
In 2024, the company's operating income declined due to factors such as client fund constraints, project tender delays, and delivery acceptance delays. Additionally, due to the above-mentioned client fund constraints and lengthy approval processes, the company's accounts receivable increased in size. However, the company's main clients are government agencies, large enterprises, and institutions with good credit and strong recoverability. Based on prudence, in accordance with the "Enterprise Accounting Standards" and accounting policies, the company made provisions for bad debts on accounts receivable based on expected credit loss rates, leading to an increase in impairment losses on credit.
Related Articles

HK Stock Market Move | KANGJI MEDICAL (09997) rose more than 6%, the company strategically invested in Weijing Medical. The institution said that the surgical consumables of Siasun Robot & Automation are expected to increase significantly.

HK Stock Market Move | SIPAI HEALTH (00314) rose more than 46% in midday trading. The National Health Insurance Administration will add commercial health insurance innovative drugs to the catalogue.

HK Stock Market Move | EAST BUY (01797) rises over 7%. The company is focusing on proprietary products. Institutions previously stated that its GMV has rebounded after hitting bottom.
HK Stock Market Move | KANGJI MEDICAL (09997) rose more than 6%, the company strategically invested in Weijing Medical. The institution said that the surgical consumables of Siasun Robot & Automation are expected to increase significantly.

HK Stock Market Move | SIPAI HEALTH (00314) rose more than 46% in midday trading. The National Health Insurance Administration will add commercial health insurance innovative drugs to the catalogue.

HK Stock Market Move | EAST BUY (01797) rises over 7%. The company is focusing on proprietary products. Institutions previously stated that its GMV has rebounded after hitting bottom.
